Can tamoxifen cause a significant mammographic density change in breast parenchyma?
- 31 October 2001
- journal article
- Published by Elsevier in Clinical Imaging
- Vol. 25 (5) , 303-308
- https://doi.org/10.1016/s0899-7071(01)00329-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Tamoxifen in the Treatment of Breast CancerNew England Journal of Medicine, 1998
- Endometrial carcinoma associated with breast carcinoma: Low incidence with tamoxifen useCancer, 1996
- Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal womenBone and Mineral, 1993
- Long term effects of tamoxifen on blood lipid values in breast cancer.BMJ, 1992
- Enlarging occult fibroadenomas.Radiology, 1992
- Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.BMJ, 1991
- Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study.Radiology, 1990
- Hormonal replacement therapy: mammographic manifestations.Radiology, 1990
- Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two yearsBreast Cancer Research and Treatment, 1988
- Estrogen and the Postmenopausal BreastPublished by American Medical Association (AMA) ,1978